Evidence map›Paper›PMID 31397090›Full record

ArticlePhysiological reports2019

The serine-threonine kinase PIM3 is an aldosterone-regulated protein in the distal nephron.

Alessia Spirli, Lydie Cheval, Anne Debonneville, David Penton, Caroline Ronzaud, Marc Maillard, Alain Doucet, Johannes Loffing, Olivier Staub

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Physiological reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Alessia SpirliDepartment of Pharmacology & Toxicology, University of Lausanne, Lausanne, Switzerland.
Lydie ChevalCentre de Recherche des Cordeliers, INSERM, Sorbonne Universités, USPC, Université Paris Descartes, Université Paris Diderot, Physiologie Rénale et Tubulopathies, Paris, France.
Anne DebonnevilleDepartment of Pharmacology & Toxicology, University of Lausanne, Lausanne, Switzerland.
David PentonNational Centre of Competence in Research "Kidney.ch", Lausanne, Switzerland.
Caroline RonzaudDepartment of Pharmacology & Toxicology, University of Lausanne, Lausanne, Switzerland.
Marc MaillardService of Nephrology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Alain DoucetCentre de Recherche des Cordeliers, INSERM, Sorbonne Universités, USPC, Université Paris Descartes, Université Paris Diderot, Physiologie Rénale et Tubulopathies, Paris, France.
Johannes LoffingNational Centre of Competence in Research "Kidney.ch", Lausanne, Switzerland.
Olivier StaubDepartment of Pharmacology & Toxicology, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-1799-9784
University Hospital of Lausanne · CHInserm · FRUniversity of Zurich · CH

Funding

Swiss National Science Foundation 310030_159735
6 · The paper itself

Abstract

The mineralocorticoid hormone aldosterone plays a crucial role in the control of Na

Indexed as

AldosteroneAnimalsKidneyMaleMice, Inbred C57BLNephronsNuclear ProteinsPhenotypeProtein Serine-Threonine KinasesSodiumTranscription FactorsAldosteroneNuclear ProteinsProtein Serine-Threonine KinasesSodiumTranscription FactorsBlood pressureblood volumekidneysteroid hormone

Identifiers

PMID31397090
PMCPMC6687858
OpenAlexW2968886929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.